These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 35333774)

  • 1. Local anesthetic levobupivacaine inhibits stemness of osteosarcoma cells by epigenetically repressing MAFB though reducing KAT5 expression.
    Wang Z; Song Y; Zhang H; Yang Y; Zhang S; Wang W
    Aging (Albany NY); 2022 Mar; 14(6):2793-2804. PubMed ID: 35333774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MAFB Promotes Cancer Stemness and Tumorigenesis in Osteosarcoma through a Sox9-Mediated Positive Feedback Loop.
    Chen Y; Wang T; Huang M; Liu Q; Hu C; Wang B; Han D; Chen C; Zhang J; Li Z; Liu C; Lei W; Chang Y; Wu M; Xiang D; Chen Y; Wang R; Huang W; Lei Z; Chu X
    Cancer Res; 2020 Jun; 80(12):2472-2483. PubMed ID: 32234710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine suppresses proliferation and induces ferroptosis and apoptosis of breast cancer cells by targeting KAT5/GPX4 axis.
    Li H; Liu W; Zhang X; Wu F; Sun D; Wang Z
    Biochem Biophys Res Commun; 2021 Dec; 585():111-116. PubMed ID: 34800882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA circPIP5K1A contributes to cancer stemness of osteosarcoma by miR-515-5p/YAP axis.
    Shi P; Li Y; Guo Q
    J Transl Med; 2021 Nov; 19(1):464. PubMed ID: 34774083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA circRHOT1 contributes to pathogenesis of non-small cell lung cancer by epigenetically enhancing C-MYC expression through recruiting KAT5.
    Ren X; Yu J; Guo L; Ma H
    Aging (Albany NY); 2021 Aug; 13(16):20372-20382. PubMed ID: 34406978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GREM1 overexpression inhibits proliferation, migration and angiogenesis of osteosarcoma.
    Gu Q; Luo Y; Chen C; Jiang D; Huang Q; Wang X
    Exp Cell Res; 2019 Nov; 384(1):111619. PubMed ID: 31525341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA HIF2PUT inhibited osteosarcoma stem cells proliferation, migration and invasion by regulating HIF2 expression.
    Zhao D; Wang S; Chu X; Han D
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1342-1348. PubMed ID: 30966832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the FOXM1-regulated long noncoding RNA TUG1 in osteosarcoma.
    Li Y; Zhang T; Zhang Y; Zhao X; Wang W
    Cancer Sci; 2018 Oct; 109(10):3093-3104. PubMed ID: 30099814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-223 targeting MAFB suppresses proliferation and migration of nasopharyngeal carcinoma cells.
    Yang W; Lan X; Li D; Li T; Lu S
    BMC Cancer; 2015 Jun; 15():461. PubMed ID: 26055874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circMRPS35 regulates progression and autophagy in osteosarcoma cells by recruiting KAT6B to govern FOXO3.
    Jiang C; Jiang Z; Zhang X
    Anticancer Drugs; 2022 Aug; 33(7):607-613. PubMed ID: 35503036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1.
    Zhang Y; Wang F; Wang L; Zhang Q
    World J Surg Oncol; 2020 May; 18(1):83. PubMed ID: 32357945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA‑487b‑3p inhibits osteosarcoma chemoresistance and metastasis by targeting ALDH1A3.
    Cheng M; Duan PG; Gao ZZ; Dai M
    Oncol Rep; 2020 Dec; 44(6):2691-2700. PubMed ID: 33125503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of miR‑95-3p inhibits growth of osteosarcoma by targeting HDGF.
    Liu X; Ma W; Ma J; Xiao L; Hao D
    Pathol Res Pract; 2019 Aug; 215(8):152492. PubMed ID: 31257090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β is associated with poor prognosis and promotes osteosarcoma progression
    Ma K; Zhang C; Li W
    Cell Cycle; 2020 Sep; 19(18):2327-2339. PubMed ID: 32804027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cinobufagin Suppresses The Characteristics Of Osteosarcoma Cancer Cells By Inhibiting The IL-6-OPN-STAT3 Pathway.
    Zhang C; Ma K; Li WY
    Drug Des Devel Ther; 2019; 13():4075-4090. PubMed ID: 31824138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
    Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
    Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W; Shan Z; Zhou X; Peng L; Zhi C; Chai J; Liu H; Yang J; Zhang Z
    Cancer Biomark; 2018; 23(4):589-601. PubMed ID: 30475755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of RBM10 induces osteosarcoma cell apoptosis and inhibits cell proliferation and migration.
    Han LP; Wang CP; Han SL
    Med Sci (Paris); 2018 Oct; 34 Focus issue F1():81-86. PubMed ID: 30403180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly-expressed P2X7 receptor promotes growth and metastasis of human HOS/MNNG osteosarcoma cells via PI3K/Akt/GSK3β/β-catenin and mTOR/HIF1α/VEGF signaling.
    Zhang Y; Cheng H; Li W; Wu H; Yang Y
    Int J Cancer; 2019 Aug; 145(4):1068-1082. PubMed ID: 30761524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The histone acetyltransferase HBO1 functions as a novel oncogenic gene in osteosarcoma.
    Gao YY; Ling ZY; Zhu YR; Shi C; Wang Y; Zhang XY; Zhang ZQ; Jiang Q; Chen MB; Yang S; Cao C
    Theranostics; 2021; 11(10):4599-4615. PubMed ID: 33754016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.